Oramed Pharmaceuticals
ORMP
ORMP
88 hedge funds and large institutions have $29.6M invested in Oramed Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
41% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 34
62% less capital invested
Capital invested by funds: $78.4M → $29.6M (-$48.7M)
Holders
88
Holding in Top 10
–
Calls
$854K
Puts
$228K
Top Buyers
| 1 | +$2.12M | |
| 2 | +$1.65M | |
| 3 | +$1.46M | |
| 4 |
E
Ergoteles
New York
|
+$1.03M |
| 5 |
Millennium Management
New York
|
+$993K |
Top Sellers
| 1 | -$7.75M | |
| 2 | -$3.33M | |
| 3 | -$2.92M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.25M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$1.46M |